2026-10-05
Dexcom's Stelo keeps first place today at 9.3, and the EASD research covered by Citeline Medtech Insight is the reference that best explains why I keep it there over sensors with higher raw accuracy. The studies show CGMs reduce mortality in the populations that use them consistently, but also that awareness and adherence lag the clinical benefit, which makes dailyCost the column that decides whether someone actually keeps wearing a sensor. Stelo's 9.5 dailyCost score, the best on this list, is why it beats the Dexcom G7 15 Day despite the G7's superior 9.8 accuracy score, a sensor nobody can afford to wear consistently helps no one.
MedTech Dive's coverage of Dexcom and Abbott's over-the-counter push adds the market context, both companies are racing to make glucose data available without a prescription, and that race is exactly why Abbott's Lingo holds third at 9.0 with a strong 9.2 app score, the OTC category is being won on software experience as much as sensor chemistry at this point.
For anyone with diagnosed diabetes who needs the highest accuracy regardless of cost, the Dexcom G7 15 Day at second with 9.1 remains my pick, its 9.8 accuracy and 8.5 coaching scores are built for clinical management, the use case it handles best. For everyone else watching metabolic health without a prescription, Stelo's combination of low cost and strong wear time is still the more sustainable choice.
Mortality benefit only matters if people keep wearing the sensor
EASD research cited by Citeline shows CGMs reduce mortality, but adherence lags. Stelo's 9.5 dailyCost score, the best here, is why affordability outranks raw accuracy in my formula.
The OTC race is being won on software now
MedTech Dive's coverage of Dexcom and Abbott's over-the-counter push lines up with Abbott Lingo's 9.2 app score. Sensor chemistry is converging, so the app experience is the new differentiator.
G7 15 Day is still the clinical pick
For diagnosed diabetics who need the highest accuracy regardless of cost, the G7 15 Day's 9.8 accuracy and 8.5 coaching scores outweigh Stelo's affordability advantage.